Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists-Reference-Cited by-同舟云学术

Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists

Published:2019-04 Issue:12 Volume:73 Page:1596-1598
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Vaduganathan Muthiah,Patel Ravi B.,Singh Avinainder,McCarthy Cian P.,Qamar Arman,Januzzi James L.,Scirica Benjamin M.,Butler Javed,Cannon Christopher P.,Bhatt Deepak L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference3 articles.

1. Prescriber patterns of SGLT2i after expansions of U.S. Food and Drug Administration labeling;Vaduganathan;J Am Coll Cardiol,2018

2. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the ADA and the EASD;Davies;Diabetologia,2018

3. 2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a report of the ACC Task Force on Expert Consensus Decision Pathways;Das;J Am Coll Cardiol,2018

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to build an actionable narrative for cardio-oncology;Trends in Cardiovascular Medicine;2024-06

2. GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?;Current Atherosclerosis Reports;2024-05-29

3. Paradoxical real-life underuse of GLP-1 receptor agonists in type 2 diabetes patients with atherosclerotic cardiovascular disease;Diabetes Epidemiology and Management;2024-04

4. Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE);Clinical Drug Investigation;2024-03-20

5. Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies;Cardiovascular Diabetology;2024-03-18